Doing evidence-based medicine? How NHS managers ration high-cost drugs

David Hughes and Shane Doheny

Social Science & Medicine, 2019, vol. 235, issue C, -

Abstract: •Funding high-cost drugs depends on a pragmatic, time-limited review of evidence.•For funding to be approved both efficacy and exceptionality must be found.•Tensions arise when efficacy but not exceptionality is present.•Decision rules change over time due to political intervention and judicial review.•Moral concerns about the value of a few extra months of life may affect decisions.

Keywords: UK; Rationing; Evidence-based medicine; High-cost drugs; NHS managers; Individual patient commissioning; Individual funding requests (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0277953619302734
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:socmed:v:235:y:2019:i:c:28

Ordering information: This journal article can be ordered from
http://www.elsevier.com/wps/find/supportfaq.cws_home/regional
http://www.elsevier. ... _01_ooc_1&version=01

DOI: 10.1016/j.socscimed.2019.05.009

Access Statistics for this article

Social Science & Medicine is currently edited by Ichiro (I.) Kawachi and S.V. (S.V.) Subramanian

More articles in Social Science & Medicine from Elsevier
Bibliographic data for series maintained by Catherine Liu ().